| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.44 | 0.04 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.04 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.36 | 0.04 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.084 | 0.05 |